Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?

Competing Interests: Steven G. WaguespackHonoraria: BayerConsulting or Advisory Role: Bayer Sanjit O. TewariStock and Other Ownership Interests: CoapTech, Starton Therapeutics, Clovis Oncology, Intrommune Therapeutics, Aurie, UE Life Sciences, DocPanelConsulting or Advisory Role: CoapTech Naifa L. BusaidyHonoraria: Eisai, ExelixisConsulting or Advisory Role: Loxo, EisaiResearch Funding: GlaxoSmithKline/Novartis Mark E. ZafereoResearch Funding: Merck, LillyOpen Payments Link: https://openpaymentsdata.cms.gov/physician/923970No other potential conflicts of interest were reported.